Are survival predictions reliable? Hospital volume versus standardisation of histopathologic reporting for accuracy of survival estimates after pancreatoduodenectomy for adenocarcinoma

European Journal of Cancer

Volumn 45, Issue 16, 2009, Pages 2850-2859

  Westgaard, Arne ^a   Larønningen, Siri ^b   Mellem, Christine ^b   Eide, Tor J ^a   Clausen, Ole Petter F ^a   Møller, Bjørn ^b   Gladhaug, Ivar P ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b CANCER REGISTRY OF NORWAY   (Norway)

Author keywords

Hospital volume; Long term survival; Lymph node involvement; Pancreatic head adenocarcinoma; Standardised histopathologic reporting; Surgical resection

Indexed keywords

AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER SIZE; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA; AGED; FEMALE; HEALTH FACILITY SIZE; HUMANS; MALE; NORWAY; OBSERVER VARIATION; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PATHOLOGY, CLINICAL; SURVIVAL ANALYSIS;

EID: 70350029839     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.03.019     Document Type: Article

References (50)

1. Ghaneh P., Costello E., and Neoptolemos J.P. Biology and management of pancreatic cancer. Gut 56 8 (2007) 1134-1152
2. Riall T.S., Cameron J.L., Lillemoe K.D., et al. Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Surgery 140 5 (2006) 764-772
3. Vulfovich M., and Rocha-Lima C. Novel advances in pancreatic cancer treatment. Expert Rev Anticancer Ther 8 6 (2008) 993-1002
4. Strimpakos A., Saif M.W., and Syrigos K.N. Pancreatic cancer: from molecular pathogenesis to targeted therapy. Cancer Metastasis Rev 27 3 (2008) 495-522
5. Staley C.A., Cleary K.R., Abbruzzese J.L., et al. The need for standardized pathologic staging of pancreaticoduodenectomy specimens. Pancreas 12 4 (1996) 373-380
6. In: Hruban R.H., Westra W.H., Phelps T.H., and Isacson C. (Eds). Surgical pathology dissection (1996), Springer-Verlag Telos, New York
7. Luttges J., Zamboni G., and Kloppel G. Recommendation for the examination of pancreaticoduodenectomy specimens removed from patients with carcinoma of the exocrine pancreas. A proposal for a standardized pathological staging of pancreaticoduodenectomy specimens including a checklist. Dig Surg 16 4 (1999) 291-296
8. Albores-Saavedra J., Heffess C., Hruban R.H., Klimstra D., and Longnecker D. Recommendations for the reporting of pancreatic specimens containing malignant tumors. The Association of Directors of Anatomic and Surgical Pathology. Am J Clin Pathol 111 3 (1999) 304-307
9. In: Greene F.L. (Ed). AJCC cancer staging manual (2002), Springer, New York
10. The Royal College of Pathologists. Standards and minimum datasets for reporting cancers. minimum dataset for the histopathological reporting of pancreatic, ampulla of vater and bile duct carcinoma. Datasets and tissue pathways 2002 February. [accessed January 3 2009].
11. Demetter P., and Cuvelier C.A. Guidelines for adequate histopathological reporting of pancreatic ductal adenocarcinoma resection specimens. Acta Gastroenterol Belg 67 1 (2004) 46-49
12. College of American Pathologists. Cancer protocols and checklists: pancreas (exocrine). Ampulla of Vater. Extrahepatic bile ducts. Small intestine. Reference resources and publications 2005 January [accessed January 3 2009].
13. Verbeke C.S., Leitch D., Menon K.V., McMahon M.J., Guillou P.J., and Anthoney A. Redefining the R1 resection in pancreatic cancer. Br J Surg 93 10 (2006) 1232-1237
14. Westgaard A., Tafjord S., Farstad I.N., et al. Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor. BMC Cancer 8 (2008) 5
15. Esposito I., Kleeff J., Bergmann F., et al. Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 6 (2008) 1651-1660
16. Oettle H., Post S., Neuhaus P., et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297 3 (2007) 267-277
17. Bilimoria K.Y., Talamonti M.S., Wayne J.D., et al. Effect of hospital type and volume on lymph node evaluation for gastric and pancreatic cancer. Arch Surg 143 7 (2008) 671-678
18. Ampulla of Vater. In: Greene F.L. (Ed). AJCC cancer staging manual (2002), Springer, New York 151-156
19. Albores-Saavedra J., Henson D.E., and Klimstra D.S. Malignant epithelial tumors of the ampulla. Tumors of the gallbladder, extrahepatic bile ducts, and ampulla of Vater (2000), Armed Forces Institute of Pathology, Washington (DC) p. 259-316
20. Fisher W., and Bakey M. Differences between ampullary, periampullary and pancreatic cancer. World J Surg 31 1 (2007) 144-146
21. Howe J.R., Klimstra D.S., Moccia R.D., Conlon K.C., and Brennan M.F. Factors predictive of survival in ampullary carcinoma. Ann Surg 228 1 (1998) 87-94
22. Schirmacher P., and Buchler M.W. Ampullary adenocarcinoma - differentiation matters. BMC Cancer 8 (2008) 251
23. Westgaard A., Tafjord S., Farstad I.N., et al. Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma. BMC Cancer 8 (2008) 170
24. Carpelan-Holmstrom M., Nordling S., Pukkala E., et al. Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 54 3 (2005) 385-387
25. Sarmiento J.M., Nagomey D.M., Sarr M.G., and Farnell M.B. Periampullary cancers: are there differences?. Surg Clin North Am 81 3 (2001) 543-555
26. Larsen IK, Småstuen M, Parkin DM, Bray F. Data quality at the Cancer Registry of Norway. Cancer in Norway 2006 - Cancer incidence, mortality, survival and prevalence in Norway. Oslo, Cancer Registry of Norway; 2007.
27. The Ministry of Health and Social Affairs. Regulations on the collection and processing of personal health data in the Cancer Registry of Norway (Cancer Registry Regulations). Regulations of 21 December 2001 No. 1477 2001 December 21 [accessed Jan 3 2009].
28. Hruban R.H., Adsay N.V., Albores-Saavedra J., et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 25 5 (2001) 579-586
29. Verbeke C.S. Resection margins and R1 rates in pancreatic cancer-are we there yet?. Histopathology 52 7 (2008) 787-796
30. Tveit KM, Giercksky K-E, Dahl O. Kapittel 26: Gastrointestinal kreft. Cytostatika: medikamentell kreftbehandling 2002 December. [accessed March 2 2009].
31. Tomlinson J.S., Jain S., Bentrem D.J., et al. Accuracy of staging node-negative pancreas cancer: a potential quality measure. Arch Surg 142 8 (2007) 723-767
32. Shimada K., Sakamoto Y., Sano T., Kosuge T., and Hiraoka N. Reappraisal of the clinical significance of tumor size in patients with pancreatic ductal carcinoma. Pancreas 33 3 (2006) 233-239
33. Birkmeyer J.D., Siewers A.E., Finlayson E.V.A., et al. Hospital volume and surgical mortality in the United States. New Engl J Med 346 15 (2002) 1128-1137
34. Bilimoria K.Y., Bentrem D.J., Feinglass J.M., et al. Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. J Clin Oncol 26 28 (2008) 4626-4633
35. Hamilton S.R., and Aaltonen L.A. Pathology and genetics of tumours of the digestive system (2000), IARC Press, Lyon
36. Hruban R.H., and Fukushima N. Pancreatic adenocarcinoma: update on the surgical pathology of carcinomas of ductal origin and PanINs. Mod Pathol 20 suppl. 1 (2007) S61-S70
37. Albores-Saavedra J., Henson D.E., and Klimstra D.S. Tumors of the gallbladder, extrahepatic bile ducts, and ampulla of Vater (2000), Armed Forces Institute of Pathology, Washington (DC)
38. Albores-Saavedra J., Simpson K., Dancer Y.J., and Hruban R. Intestinal type adenocarcinoma: a previously unrecognized histologic variant of ductal carcinoma of the pancreas. Ann Diagn Pathol 11 1 (2007) 3-9
39. Matsumoto K., Mizoshita T., Tsukamoto T., et al. Cdx2 expression in pancreatic tumors: relationship with prognosis of invasive ductal carcinomas. Oncol Rep 12 6 (2004) 1239-1243
40. Hong S.M., Cho H., Moskaluk C.A., Frierson Jr. H.F., Yu E., and Ro J.Y. CDX2 and MUC2 protein expression in extrahepatic bile duct carcinoma. Am J Clin Pathol 124 3 (2005) 361-370
41. Albores-Saavedra J., Henson D.E., and Klimstra D.S. Dysplasia, carcinoma in situ, and invasive carcinoma of the extrahepatic bile ducts. Tumors of the gallbladder, extrahepatic bile ducts, and ampulla of Vater (2000), Armed Forces Institute of Pathology, Washington (DC) p. 191-215
42. Kimura W., Futakawa N., Yamagata S., et al. Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater. Jpn J Cancer Res 85 2 (1994) 161-166
43. Albores-Saavedra J., Menck H.R., Scoazec J.C., et al. Carcinoma of the gallbladder and extrahepatic bile ducts. In: Hamilton S.R., and Aaltonen L.A. (Eds). Pathology and genetics of tumours of the digestive system (2000), IARC Press, Lyon 206-213
44. Zhou H., Schaefer N., Wolff M., and Fischer H.P. Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up. Am J Surg Pathol 28 7 (2004) 875-882
45. Westgaard A., Schjolberg A.R., Cvancarova M., Eide T.J., Clausen O.P.F., and Gladhaug I.P. Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours. Histopathology 54 3 (2009) 337-347
46. Monson J.R., Donohue J.H., McEntee G.P., et al. Radical resection for carcinoma of the ampulla of Vater. Arch Surg 126 3 (1991) 353-357
47. In: Sobin L.H., and Wittekind C. (Eds). TNM classification of malignant tumours. 6th ed. (2002), Wiley-Liss, New York
48. Frierson Jr. H.F. The gross anatomy and histology of the gallbladder, extrahepatic bile ducts, Vaterian system, and minor papilla. Am J Surg Pathol 13 2 (1989) 146-162
49. Carter J.T., Grenert J.P., Rubenstein L., Stewart L., and Way L.W. Tumors of the ampulla of vater: histopathologic classification and predictors of survival. J Am Coll Surg 207 2 (2008) 210-218
50. Neoptolemos J.P., Stocken D.D., Dunn J.A., et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 234 6 (2001) 758-768